https://www.hcplive.com/view/c-diff-vaccine-shows-lot-consistency-induces-toxin-a-and-b-antibody-responses
0
0
12/8/23 at 5:09pm
Organization
Hcplive.com
Data from the phase 3 study confirmed the lot consistency, immunogenicity, safety, and tolerability of a toxoid-based Clostridioides difficile vaccine.
Create an account
or login to join the discussion